ActiGraph LEAP™: The multi-sensing wearable for patient-centric clinical trials

A sleeping woman wearing the ActiGraph LEAP™ © ActiGraph

How wearable devices can improve clinical research and patient outcomes

Wearable technology can collect real-time data and monitor patient conditions in various settings, providing a more accurate and objective picture of health status than self-reporting. However, patient adherence to wearable devices is a key challenge that needs to be addressed by manufacturers and providers. They can do so by introducing innovative solutions that meet the needs and preferences of the users, and by prioritizing user-centric design that enhances the usability and functionality of the devices. By improving patient adherence, wearable technology can contribute to better healthcare outcomes and other advancements.

A new standard in patient-centered clinical research

ActiGraph is a leader in wearable digital health technology and end-to-end services. Its products and services are used by academic and industry researchers to measure the effects of treatments and interventions on patients’ health and quality of life. In 2023, ActiGraph unveiled its most advanced wearable to date, the ActiGraph LEAP™. This device collects continuous, multi-sensor data, offering unparalleled insights into participants’ real-world functioning. Its design prioritizes participant comfort and adherence particularly via its passive data collection and stylish aesthetic. The device is US FDA 510 (k) cleared and features one of the most comprehensive sensor collections in the industry.

CSEM’s expertise the key to ActiGraph LEAP™ performance

ActiGraph LEAP™ smart wearable device.© ActiGraph - ActiGraph LEAP™ smart device.

“We collaborated with ActiGraph in developing the LEAP™, a device that uses our optical inertial sensing technology to measure human vital signs and kinetics,” notes Mathieu Lemay, Signal Processing Group Leader at CSEM. “This technology offers several benefits such as easy integration, high signal quality, and reliable and accurate measurements of various biomarkers and physiological parameters. These include heart rate and variability, oxygen saturation, human kinetics, skin temperature, and more. The wearable also provides real-time feedback and remote monitoring and data transmission,” he adds. The data is further processed and analyzed using CSEM’s advanced algorithms in the ActiGraph cloud, a secure and scalable platform that supports data management and analytics for clinical trials.

“These parameters are important indicators of health and wellness and can provide valuable insights into the mechanisms and outcomes of various therapies,” says Jeremy Wyatt, the CEO of ActiGraph. “CSEM has supported the design, testing, and validation of LEAP™, a digital tool which has helped us expand our device portfolio,” Wyatt summarizes. “The tool enables personalized medicine by providing an end-to-end patient-centric data solution for clinical research.

The device set to transform society and healthcare

ActiGraph’s new device goes beyond business benefits; indeed, it could trigger societal changes. With a product that measures innovative biomarkers and physiological parameters, LEAP™ aims for better and more precise drug trials, more effective and personalized treatments, improved quality of life for patients, and reduced healthcare costs. Additionally, by combining multiple sensors in one device, the wearable enables a more holistic and comprehensive understanding of human health and behavior. CSEM is proud to be part of this innovation.

Looking for Digital Health solutions?

Contact us today if you would like to learn more. Or refer to our expertise in Digital Health for more information on how we could help you.